サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1398382

塩基編集の世界市場：製品・サービス別、タイプ別、標的塩基別、用途別、エンドユーザー別、地域別-2028年までの予測

Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), and Region - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 265 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
塩基編集の世界市場：製品・サービス別、タイプ別、標的塩基別、用途別、エンドユーザー別、地域別-2028年までの予測
出版日: 2023年12月14日
発行: MarketsandMarkets
ページ情報: 英文 265 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要
調査範囲
調査対象年 2021年～2028年
基準年 2022年
予測期間 2023年～2028年
検討単位 金額（100万米ドル）
セグメント 製品・サービス別、タイプ別、標的塩基別、用途別、エンドユーザー別
対象地域 北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ

塩基編集の市場規模は、2023年の2億7,000万米ドルから2028年には5億4,900万米ドルに達すると予測され、予測期間中のCAGRは15.2%になるとみられています。

同市場の成長は、新規遺伝子治療と個別化医療に対する需要の高まりと、新たに操作された分子の開発に起因しています。その結果、希少な遺伝性疾患の治療や遺伝子組み換え作物の収穫量の増加が期待され、市場全体の成長を後押ししています。様々な疾患における遺伝子変異の役割に対する認識の高まりが、精密な遺伝子編集技術に対する需要を煽っています。疾患の原因となる変異を修正する塩基編集の能力は、遺伝性疾患への対処におけるその関連性に寄与しています。

2022年、世界の塩基編集市場では、プラットフォームセグメントが製品・サービスで最大のシェアを占めました。塩基編集プラットフォームのような要素は、ガイドRNAの設計から標的細胞への塩基編集剤の送達までのワークフロー全体をカバーするエンドツーエンドのソリューションを提供します。この包括的なアプローチは、研究者の実験プロセスを簡素化し、個々のコンポーネントよりもプラットフォームの人気の一因となっている可能性があります。

北米は2022年に世界の塩基編集市場を独占しました。北米では、個別化医療、精密治療、遺伝性疾患の治療に力を入れているため、高度な遺伝子編集技術に対する需要が高いとみられています。その結果、同地域の企業は塩基編集技術の導入と投資に傾倒しています。さらに北米には、分子生物学、遺伝学、バイオテクノロジーの分野で十分な教育を受けた熟練労働力がいます。有能な労働力の存在は、この地域が先進的なゲノム編集技術の開発と応用をリードする能力に貢献しています。こうした要因が北米のゲノム編集市場の成長に寄与しています。

当レポートでは、世界の塩基編集市場について調査し、製品・サービス別、タイプ別、標的塩基別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 顧客のビジネスに影響を与える動向/混乱
  • 価格分析
  • バリューチェーン分析
  • サプライチェーン分析
  • 生態系市場マップ
  • 技術分析
  • 特許分析
  • 主要な会議とイベント
  • 規制シナリオ
  • ポーターのファイブフォース分析
  • 主要な利害関係者と購入基準

第6章 塩基編集市場、製品・サービス別

  • イントロダクション
  • 製品
  • サービス

第7章 塩基編集市場、タイプ別

  • イントロダクション
  • DNAベースの編集
  • RNAベースの編集

第8章 塩基編集市場、標的塩基別

  • イントロダクション
  • シトシン塩基編集
  • アデニン塩基編集

第9章 塩基編集市場、用途別

  • イントロダクション
  • 創薬と開発
  • 農業
  • 獣医

第10章 塩基編集市場、エンドユーザー別

  • イントロダクション
  • 製薬会社およびバイオテクノロジー企業
  • 学術研究機関
  • CRO

第11章 塩基編集市場、地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第12章 競合情勢

  • 概要
  • 主要参入企業が採用した戦略
  • 市場参入企業上位5社の収益シェア分析
  • 市場シェア分析
  • 企業評価マトリックス
  • スタートアップ/中小企業の評価マトリックス
  • 競争シナリオと動向

第13章 企業プロファイル

  • 主要参入企業
    • DANAHER CORPORATION
    • BEAM THERAPEUTICS
    • MERCK KGAA
    • REVVITY
    • MARAVAI LIFESCIENCES
    • GENSCRIPT
    • INTELLIA THERAPEUTICS, INC.
    • CELLECTIS
    • ELEVATEBIO
    • CREATIVE BIOGENE
    • BIO PALETTE CO., LTD.
    • ADDGENE
    • SYNTHEGO
    • EDIGENE INC.
    • SHAPETX
  • その他の企業
    • PAIRWISE
    • PROQR THERAPEUTICS
    • QI-BIODESIGN TECHNOLOGY
    • KROMATID, INC.
    • GENKORE

第14章 付録

目次
Product Code: BT 8891

Report Description

Scope of the Report
Years Considered for the Study2021-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) Million
SegmentsProduct & Service, Type, Targeted Base, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

The Base editing market is projected to reach USD 549 million by 2028 from an estimated USD 270 million in 2023, at a CAGR of 15.2% during the forecast period. The growth of this market can be attributed to the growing demand for novel genetic therapies and personalized medicine, coupled with the development of newly engineered molecules. That is expected to treat rare genetic disorders and increase the yield of genetically modified crops, propelling the growth of the overall market. The increasing recognition of the role of genetic mutations in various diseases has fueled the demand for precise gene editing technologies. Base editing's ability to correct disease-causing mutations contributes to its relevance in addressing genetic disorders.

"The platform segment accounted for the largest share by product & services in 2022."

In 2022, the platform segment accounted for the largest share of product & service in the global base editing market. The factors like base editing platforms offer end-to-end solutions that cover the entire workflow from designing guide RNAs to delivering base editors into target cells. This comprehensive approach simplifies the experimentation process for researchers and may contribute to the popularity of platforms over individual components.

"The North America region continued to dominate the base editing market during the forecast period of 2023-2028."

North America dominated the global base editing market in 2022. The demand for advanced gene editing technologies is high in North America due to the region's focus on personalized medicine, precision therapeutics, and the treatment of genetic disorders. As a result, companies in the region are more inclined to adopt and invest in base editing technologies. Moreover, North America has a well-educated and skilled workforce in the fields of molecular biology, genetics, and biotechnology. The availability of a talented workforce contributes to the region's ability to lead in the development and application of advanced genomic editing technologies. These factors are contributing to the growth of the North American base editing market.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

  • Danaher Corporation (US)
  • Merck KGaA (Germany)
  • Revvity (US)
  • Maravai LifeSciences (US)
  • GenScript (China)
  • Beam Therapeutics (US)
  • Intellia Therapeutics, Inc. (US)
  • Cellectis (France)
  • ElevateBio (US)
  • Creative Biogene (US)
  • Bio Palette Co., Ltd (Japan)
  • Addgene (US)
  • Synthego (US)
  • EdiGene, Inc. (China)
  • Shape TX (US)
  • Pairwise (US)
  • ProQR Therapeutics (Netherlands)
  • QI-Biodesign (China)
  • KromaTiD, Inc. (US)
  • GenKOre. (South Korea).

Research Coverage:

This research report categorizes the base editing market by product & service (service (gRNA design, cell line engineering, and other services) product (platforms, kits & reagents, plasmids, and base editing libraries), by targeted base (cytosine base editor, adenine base editor), by type (DNA base editing, RNA base editing), by application (drug discovery & development, agriculture, and veterinary), by end user (pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations).

The report's scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the base editing market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, in the base editing market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall base editing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (the rising government funding and growth of genomics studies, increased applications of genomics in pharmaceuticals, rising prevalence of rare diseases, and increased precision & reduced off-target effects with base editing), restraints (ethical & safety concerns), opportunities (Increasing pipeline of gene therapy & regulatory approvals), and challenges (Challenges associated with off-target effects) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products in the base editing market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the base editing market
  • Competitive Assessment: Danaher Corporation (US), Merck KGaA (Germany), Revvity (US), Maravai LifeSciences (US), GenScript (China), Beam Therapeutics (US), Intellia Therapeutics, Inc. (US), Cellectis (France), ElevateBio (US), Creative Biogene (US), Bio Palette Co., Ltd (Japan), Addgene (US), Synthego (US), EdiGene, Inc. (China), Shape TX (US), Pairwise (US), ProQR Therapeutics (Netherlands), QI-Biodesign (China), KromaTiD, Inc. (US), GenKOre. (South Korea) and among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION AND SCOPE
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • 1.2.3 YEARS CONSIDERED
  • 1.3 CURRENCY
  • 1.4 STAKEHOLDERS
  • 1.5 LIMITATIONS
  • 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: BASE EDITING MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 BASE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 6 BASE EDITING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
    • FIGURE 7 BASE EDITING MARKET (DEMAND-SIDE): CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 2.3.1 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RISK ANALYSIS
  • 2.6 IMPACT OF RECESSION ON BASE EDITING MARKET
    • TABLE 1 US: HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 2 US: HEALTH EXPENDITURE, 2023-2030 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 9 BASE EDITING PRODUCTS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 BASE EDITING MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 BASE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 BASE EDITING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BASE EDITING MARKET

4 PREMIUM INSIGHTS

  • 4.1 BASE EDITING MARKET OVERVIEW
    • FIGURE 14 GROWING FOCUS ON GENOMIC STUDIES TO DRIVE MARKET
  • 4.2 ASIA PACIFIC: BASE EDITING MARKET, BY APPLICATION AND COUNTRY (2022)
    • FIGURE 15 DRUG DISCOVERY & DEVELOPMENT SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.3 BASE EDITING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 SOUTH KOREA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 BASE EDITING MARKET SHARE, BY END USER, 2023
    • FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET IN 2023

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 BASE EDITING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 3 IMPACT ANALYSIS: BASE EDITING MARKET
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing government funding and growing focus on genomic studies
      • 5.2.1.2 Increased applications of genomic research in pharmaceuticals
      • 5.2.1.3 Rising prevalence of rare diseases
      • 5.2.1.4 Increased precision, better safety, and reduced off-target effects
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Ethical and safety concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing pipeline of gene therapy products and regulatory approvals
    • FIGURE 19 ONGOING CLINICAL TRIALS FOR GENE THERAPY BY PHASE (TILL Q2 2023)
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of expertise to develop base editors with higher specificity
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 20 REVENUE SHIFT AND NEW POCKETS FOR BASE EDITING PRODUCT PROVIDERS
  • 5.4 PRICING ANALYSIS
    • TABLE 4 AVERAGE SELLING PRICE OF KEY PRODUCTS IN MARKET
    • TABLE 5 COST OF PRODUCT, BY REGION
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 21 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASES ADD MAXIMUM VALUE
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 22 BASE EDITING MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM MARKET MAP
    • FIGURE 23 BASE EDITING MARKET: ECOSYSTEM MARKET MAP
    • TABLE 6 BASE EDITING MARKET: ROLE IN ECOSYSTEM
  • 5.8 TECHNOLOGY ANALYSIS
    • TABLE 7 BASE EDITING MARKET: TECHNOLOGY ANALYSIS
  • 5.9 PATENT ANALYSIS
    • FIGURE 24 PATENT APPLICATIONS FOR BASE EDITING MARKET, JANUARY 2013-OCTOBER 2023
    • TABLE 8 INDICATIVE LIST OF PATENTS IN BASE EDITING MARKET
  • 5.10 KEY CONFERENCES & EVENTS
    • TABLE 9 DETAILED LIST OF KEY CONFERENCES & EVENTS, 2023-2024
  • 5.11 REGULATORY SCENARIO
    • 5.11.1 REGULATORY ANALYSIS
    • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 15 BASE EDITING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
    • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
      • 5.13.1.1 Role of stakeholders in buying process
    • 5.13.2 BUYING CRITERIA
    • FIGURE 26 KEY BUYING CRITERIA FOR END USERS

6 BASE EDITING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 16 BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • 6.2 PRODUCTS
    • TABLE 1 BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 2 BASE EDITING PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 3 NORTH AMERICA: BASE EDITING PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 4 EUROPE: BASE EDITING PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 5 ASIA PACIFIC: BASE EDITING PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 6 LATIN AMERICA: BASE EDITING PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 7 MIDDLE EAST & AFRICA: BASE EDITING PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.1 PLATFORMS
      • 6.2.1.1 Repetitive purchase of technology platforms to support market growth
    • TABLE 8 PLATFORMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 9 NORTH AMERICA: PLATFORMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 10 EUROPE: PLATFORMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 11 ASIA PACIFIC: PLATFORMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 12 LATIN AMERICA: PLATFORMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 13 MIDDLE EAST & AFRICA: PLATFORMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2 KITS & REAGENTS
      • 6.2.2.1 Increasing prevalence of rare diseases to drive growth
    • TABLE 14 KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 15 NORTH AMERICA: KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 EUROPE: KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 ASIA PACIFIC: KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 LATIN AMERICA: KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 19 MIDDLE EAST & AFRICA: KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.3 PLASMIDS
      • 6.2.3.1 Plasmid-encoded base editors crucial tool for in vivo base editing
    • TABLE 20 PLASMIDS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 21 NORTH AMERICA: PLASMIDS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 22 EUROPE: PLASMIDS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 23 ASIA PACIFIC: PLASMIDS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 LATIN AMERICA: PLASMIDS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 MIDDLE EAST & AFRICA: PLASMIDS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.4 BASE EDITING LIBRARIES
      • 6.2.4.1 Increased application of base editing in therapeutics to drive growth
    • TABLE 26 BASE EDITING LIBRARIES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 27 NORTH AMERICA: BASE EDITING LIBRARIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 EUROPE: BASE EDITING LIBRARIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 ASIA PACIFIC: BASE EDITING LIBRARIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 LATIN AMERICA: BASE EDITING LIBRARIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 31 MIDDLE EAST & AFRICA: BASE EDITING LIBRARIES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 SERVICES
    • TABLE 32 BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 33 BASE EDITING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 34 NORTH AMERICA: BASE EDITING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 EUROPE: BASE EDITING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 ASIA PACIFIC: BASE EDITING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 LATIN AMERICA: BASE EDITING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 MIDDLE EAST & AFRICA: BASE EDITING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.1 GRNA DESIGNING
      • 6.3.1.1 Wide application of gene editing/genome engineering services to drive growth
    • TABLE 39 GRNA DESIGNING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 40 NORTH AMERICA: GRNA DESIGNING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 EUROPE: GRNA DESIGNING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: GRNA DESIGNING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 LATIN AMERICA: GRNA DESIGNING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 MIDDLE EAST & AFRICA: GRNA DESIGNING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.2 CELL LINE ENGINEERING
      • 6.3.2.1 Cell line engineering tools valuable in drug discovery and therapeutic screening
    • TABLE 45 CELL LINE ENGINEERING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 46 NORTH AMERICA: CELL LINE ENGINEERING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 47 EUROPE: CELL LINE ENGINEERING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 ASIA PACIFIC: CELL LINE ENGINEERING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 LATIN AMERICA: CELL LINE ENGINEERING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 MIDDLE EAST & AFRICA: CELL LINE ENGINEERING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.3 OTHER SERVICES
    • TABLE 51 OTHER SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 52 NORTH AMERICA: OTHER SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 EUROPE: OTHER SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: OTHER SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 LATIN AMERICA: OTHER SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 MIDDLE EAST & AFRICA: OTHER SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

7 BASE EDITING MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 57 BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 7.2 DNA BASE EDITING
    • 7.2.1 CONTINUOUS RESEARCH AND IMPROVEMENTS IN BASE EDITING TECHNOLOGY TO DRIVE MARKET
    • TABLE 58 DNA BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 59 NORTH AMERICA: DNA BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 EUROPE: DNA BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: DNA BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 62 LATIN AMERICA: DNA BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 MIDDLE EAST & AFRICA: DNA BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 RNA BASE EDITING
    • 7.3.1 REVERSIBLE TRANSITION WITH RNA BASE EDITING TO SUPPORT MARKET GROWTH
    • TABLE 64 RNA BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 65 NORTH AMERICA: RNA BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: RNA BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: RNA BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 68 LATIN AMERICA: RNA BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 69 MIDDLE EAST & AFRICA: RNA BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)

8 BASE EDITING MARKET, BY TARGETED BASE

  • 8.1 INTRODUCTION
    • TABLE 70 BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
  • 8.2 CYTOSINE BASE EDITING
    • 8.2.1 INCREASED USE IN BIOTECHNOLOGY AND AGRICULTURE TO DRIVE MARKET
    • TABLE 71 CYTOSINE BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 72 NORTH AMERICA: CYTOSINE BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 73 EUROPE: CYTOSINE BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 ASIA PACIFIC: CYTOSINE BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 LATIN AMERICA: CYTOSINE BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 MIDDLE EAST & AFRICA: CYTOSINE BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 ADENINE BASE EDITING
    • 8.3.1 ONGOING RESEARCH FOR INCREASING EFFICIENCY AND APPLICATIONS TO DRIVE MARKET
    • TABLE 77 ADENINE BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 78 NORTH AMERICA: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 LATIN AMERICA: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 82 MIDDLE EAST & AFRICA: ADENINE BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)

9 BASE EDITING MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 83 BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.2 DRUG DISCOVERY & DEVELOPMENT
    • 9.2.1 GROWING RESEARCH IN DRUG DISCOVERY TO DRIVE MARKET
    • TABLE 84 BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 85 NORTH AMERICA: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 86 EUROPE: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 87 ASIA PACIFIC: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 LATIN AMERICA: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 AGRICULTURE
    • 9.3.1 INCREASING FUNDING FROM GOVERNMENT BODIES AND PRIVATE ORGANIZATIONS TO DRIVE MARKET
    • TABLE 90 BASE EDITING MARKET FOR AGRICULTURE, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 91 NORTH AMERICA: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 EUROPE: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 LATIN AMERICA: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR AGRICULTURE, BY REGION, 2021-2028 (USD MILLION)
  • 9.4 VETERINARY
    • 9.4.1 INCREASING USE OF ANIMAL SIMULATION MODELS IN RESEARCH TO DRIVE MARKET
    • TABLE 96 BASE EDITING MARKET FOR VETERINARY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 98 EUROPE: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 LATIN AMERICA: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 101 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR VETERINARY, BY REGION, 2021-2028 (USD MILLION)

10 BASE EDITING MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 102 BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.2.1 INCREASED USE OF CRISPR-BASED TECHNOLOGIES TO DRIVE MARKET
    • TABLE 103 BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 104 NORTH AMERICA: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 105 EUROPE: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 LATIN AMERICA: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 108 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
  • 10.3 ACADEMIC & RESEARCH INSTITUTES
    • 10.3.1 GROWING FOCUS ON LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH
    • TABLE 109 BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 110 NORTH AMERICA: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 111 EUROPE: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 113 LATIN AMERICA: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 114 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
  • 10.4 CONTRACT RESEARCH ORGANIZATIONS
    • 10.4.1 GROWING ADOPTION OF STEM CELL THERAPY AND ONGOING CLINICAL RESEARCH TO PROPEL MARKET
    • TABLE 115 BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 116 NORTH AMERICA: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 117 EUROPE: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 119 LATIN AMERICA: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 120 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)

11 BASE EDITING MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 121 BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: BASE EDITING MARKET SNAPSHOT
    • TABLE 122 NORTH AMERICA: BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 123 NORTH AMERICA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 124 NORTH AMERICA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 NORTH AMERICA: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 NORTH AMERICA: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 127 NORTH AMERICA: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 128 NORTH AMERICA: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 129 NORTH AMERICA: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 Robust investment in genomics field to drive market
    • TABLE 130 US: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 131 US: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 132 US: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 133 US: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 134 US: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 135 US: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 136 US: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Availability of government funding for genomics research to support market growth
    • TABLE 137 CANADA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 138 CANADA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 139 CANADA: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 140 CANADA: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 141 CANADA: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 142 CANADA: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 143 CANADA: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.3 RECESSION IMPACT ON NORTH AMERICAN BASE EDITING MARKET
  • 11.3 EUROPE
    • TABLE 144 EUROPE: BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 145 EUROPE: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 146 EUROPE: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 EUROPE: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 EUROPE: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 EUROPE: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 150 EUROPE: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 151 EUROPE: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Strong academic base and rising awareness to drive growth
    • TABLE 152 GERMANY: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 153 GERMANY: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 154 GERMANY: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 GERMANY: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 GERMANY: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 157 GERMANY: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 158 GERMANY: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 Largest market for genome engineering in Europe
    • TABLE 159 UK: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 160 UK: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 UK: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 UK: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 163 UK: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 164 UK: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 165 UK: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Government funding for genomics to support market growth
    • TABLE 166 FRANCE: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 167 FRANCE: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 168 FRANCE: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 169 FRANCE: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 170 FRANCE: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 171 FRANCE: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 172 FRANCE: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Increasing number of workshops and conferences to propel market growth
    • TABLE 173 ITALY: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 174 ITALY: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 175 ITALY: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 176 ITALY: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 177 ITALY: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 178 ITALY: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 179 ITALY: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Increased focus on personalized medicines to boost market growth
    • TABLE 180 SPAIN: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 181 SPAIN: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 182 SPAIN: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 183 SPAIN: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 184 SPAIN: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 185 SPAIN: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 186 SPAIN: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 187 REST OF EUROPE: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 188 REST OF EUROPE: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 189 REST OF EUROPE: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 190 REST OF EUROPE: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 191 REST OF EUROPE: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 192 REST OF EUROPE: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 193 REST OF EUROPE: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.7 RECESSION IMPACT ON EUROPEAN BASE EDITING MARKET
  • 11.4 ASIA PACIFIC
    • FIGURE 28 ASIA PACIFIC: BASE EDITING MARKET SNAPSHOT
    • TABLE 194 ASIA PACIFIC: BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 195 ASIA PACIFIC: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 196 ASIA PACIFIC: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 197 ASIA PACIFIC: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 198 ASIA PACIFIC: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 199 ASIA PACIFIC: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 200 ASIA PACIFIC: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 201 ASIA PACIFIC: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.1 CHINA
      • 11.4.1.1 Government support for genomics research to favor market growth
    • TABLE 202 CHINA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 203 CHINA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 204 CHINA: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 205 CHINA: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 206 CHINA: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 207 CHINA: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 208 CHINA: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Increased focus on cancer research to propel market
    • TABLE 209 JAPAN: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 210 JAPAN: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 211 JAPAN: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 212 JAPAN: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 213 JAPAN: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 214 JAPAN: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 215 JAPAN: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Rising number of research activities to support market growth
    • TABLE 216 INDIA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 217 INDIA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 218 INDIA: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 219 INDIA: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 220 INDIA: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 221 INDIA: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 222 INDIA: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.4 SOUTH KOREA
      • 11.4.4.1 Increasing focus on gene editing research and applications to drive market
    • TABLE 223 SOUTH KOREA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 224 SOUTH KOREA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 225 SOUTH KOREA: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 226 SOUTH KOREA: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 227 SOUTH KOREA: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 228 SOUTH KOREA: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 229 SOUTH KOREA: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.5 REST OF ASIA PACIFIC
    • TABLE 230 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 231 REST OF ASIA PACIFIC: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 232 REST OF ASIA PACIFIC: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 233 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 234 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 235 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 236 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.6 RECESSION IMPACT ON ASIA PACIFIC BASE EDITING MARKET
  • 11.5 LATIN AMERICA
    • TABLE 237 LATIN AMERICA: BASE EDITING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 238 LATIN AMERICA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 239 LATIN AMERICA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 240 LATIN AMERICA: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 241 LATIN AMERICA: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 242 LATIN AMERICA: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 243 LATIN AMERICA: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 244 LATIN AMERICA: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.1 BRAZIL
      • 11.5.1.1 Need for advanced therapies to support market growth
    • TABLE 245 BRAZIL: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 246 BRAZIL: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 247 BRAZIL: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 248 BRAZIL: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 249 BRAZIL: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 250 BRAZIL: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 251 BRAZIL: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.2 MEXICO
      • 11.5.2.1 Rising demand for potential gene therapies to drive market
    • TABLE 252 MEXICO: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 253 MEXICO: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 254 MEXICO: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 255 MEXICO: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 256 MEXICO: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 257 MEXICO: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 258 MEXICO: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.3 REST OF LATIN AMERICA
    • TABLE 259 REST OF LATIN AMERICA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 260 REST OF LATIN AMERICA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 261 REST OF LATIN AMERICA: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 262 REST OF LATIN AMERICA: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 263 REST OF LATIN AMERICA: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 264 REST OF LATIN AMERICA: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 265 REST OF LATIN AMERICA: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.4 RECESSION IMPACT ON LATIN AMERICAN BASE EDITING MARKET
  • 11.6 MIDDLE EAST & AFRICA
    • TABLE 266 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 267 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 268 MIDDLE EAST & AFRICA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 269 MIDDLE EAST & AFRICA: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 270 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 271 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 272 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 273 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.6.1 MIDDLE EAST
      • 11.6.1.1 Increased focus on personalized medicine and preventive healthcare to propel market
    • TABLE 274 MIDDLE EAST: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 275 MIDDLE EAST: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 276 MIDDLE EAST: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 277 MIDDLE EAST: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 278 MIDDLE EAST: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 279 MIDDLE EAST: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 280 MIDDLE EAST: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.6.2 AFRICA
      • 11.6.2.1 Rising number of government-funded projects to support market growth
    • TABLE 281 AFRICA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 282 AFRICA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 283 AFRICA: BASE EDITING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 284 AFRICA: BASE EDITING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 285 AFRICA: BASE EDITING MARKET, BY TARGETED BASE, 2021-2028 (USD MILLION)
    • TABLE 286 AFRICA: BASE EDITING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 287 AFRICA: BASE EDITING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.6.3 RECESSION IMPACT ON MIDDLE EAST & AFRICAN BASE EDITING MARKET

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 29 STRATEGIES ADOPTED BY KEY PLAYERS, 2020-2023
  • 12.3 REVENUE SHARE ANALYSIS OF TOP FIVE MARKET PLAYERS
    • FIGURE 30 REVENUE ANALYSIS OF TOP FIVE MARKET PLAYERS, 2018-2022 (USD MILLION)
  • 12.4 MARKET SHARE ANALYSIS
    • TABLE 288 BASE EDITING MARKET: INTENSITY OF COMPETITIVE RIVALRY
  • 12.5 COMPANY EVALUATION MATRIX
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 32 BASE EDITING MARKET: COMPANY EVALUATION MATRIX, 2022
    • 12.5.5 COMPANY FOOTPRINT
    • TABLE 289 OVERALL FOOTPRINT OF COMPANIES (2022)
      • 12.5.5.1 Product & service footprint
    • TABLE 290 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (2022)
      • 12.5.5.2 Regional footprint
    • TABLE 291 REGIONAL FOOTPRINT OF COMPANIES (2022)
  • 12.6 STARTUP/SME EVALUATION MATRIX
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • FIGURE 33 BASE EDITING MARKET: STARTUP/SME EVALUATION MATRIX, 2022
    • 12.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
    • TABLE 292 BASE EDITING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • TABLE 293 BASE EDITING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • 12.7 COMPETITIVE SCENARIOS AND TRENDS
    • TABLE 294 BASE EDITING MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2020-NOVEMBER 2023
    • TABLE 295 BASE EDITING MARKET: DEALS, JANUARY 2020-NOVEMBER 2023
    • TABLE 296 BASE EDITING MARKET: OTHER DEVELOPMENTS, JANUARY 2020-NOVEMBER 2023

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 13.1.1 DANAHER CORPORATION
    • TABLE 297 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • 13.1.2 BEAM THERAPEUTICS
    • TABLE 298 BEAM THERAPEUTICS: BUSINESS OVERVIEW
    • FIGURE 35 BEAM THERAPEUTICS: COMPANY SNAPSHOT (2022)
    • 13.1.3 MERCK KGAA
    • TABLE 299 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • 13.1.4 REVVITY
    • TABLE 300 REVVITY: BUSINESS OVERVIEW
    • FIGURE 37 REVVITY: COMPANY SNAPSHOT (2023)
    • 13.1.5 MARAVAI LIFESCIENCES
    • TABLE 301 MARAVAI LIFESCIENCES: BUSINESS OVERVIEW
    • FIGURE 38 MARAVAI LIFESCIENCES: COMPANY SNAPSHOT (2022)
    • 13.1.6 GENSCRIPT
    • TABLE 302 GENSCRIPT: BUSINESS OVERVIEW
    • FIGURE 39 GENSCRIPT: COMPANY SNAPSHOT (2022)
    • 13.1.7 INTELLIA THERAPEUTICS, INC.
    • TABLE 303 INTELLIA THERAPEUTICS, INC.: BUSINESS OVERVIEW
    • FIGURE 40 INTELLIA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2022)
    • 13.1.8 CELLECTIS
    • TABLE 304 CELLECTIS: BUSINESS OVERVIEW
    • FIGURE 41 CELLECTIS: COMPANY SNAPSHOT (2022)
    • 13.1.9 ELEVATEBIO
    • TABLE 305 ELEVATEBIO: BUSINESS OVERVIEW
    • 13.1.10 CREATIVE BIOGENE
    • TABLE 306 CREATIVE BIOGENE: BUSINESS OVERVIEW
    • 13.1.11 BIO PALETTE CO., LTD.
    • TABLE 307 BIO PALETTE CO., LTD.: BUSINESS OVERVIEW
    • 13.1.12 ADDGENE
    • TABLE 308 ADDGENE: BUSINESS OVERVIEW
    • 13.1.13 SYNTHEGO
    • TABLE 309 SYNTHEGO: BUSINESS OVERVIEW
    • 13.1.14 EDIGENE INC.
    • TABLE 310 EDIGENE INC.: BUSINESS OVERVIEW
    • 13.1.15 SHAPETX
    • TABLE 311 SHAPETX: BUSINESS OVERVIEW
  • 13.2 OTHER PLAYERS
    • 13.2.1 PAIRWISE
    • 13.2.2 PROQR THERAPEUTICS
    • 13.2.3 QI-BIODESIGN TECHNOLOGY
    • 13.2.4 KROMATID, INC.
    • 13.2.5 GENKORE
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS